Alnylam Pharmaceuticals
ALNY
#814
Rank
A$44.28 B
Marketcap
A$330.94
Share price
0.23%
Change (1 day)
-51.51%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: A$685.64 AUD on 2025-10-20

Lowest end of day price: A$5.51 AUD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2026

Annual Stock Price Performance

Year Performance
2026-40.37%
2025 70.21%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$214.69-0.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$62.56-0.04%๐Ÿ‡ซ๐Ÿ‡ท France
A$1,109-1.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.12-3.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.39 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.07-1.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.86-3.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$118.52-4.15%๐Ÿ‡บ๐Ÿ‡ธ USA